“…The intermediate products N ‐(2,6‐diisopropylphenyl)acetamide, N ‐(2,6‐dimethylphenyl)acetamide, N ‐phenylbenzamide, N ‐(2,6‐dimethylphenyl)benzamide, N ‐(2,6‐dimethylphenyl)acetimidoyl chloride, N ‐(2,6‐diisopropylphenyl)acetimidoyl chloride, N ‐(2,6‐dimethylphenyl)benzenecarboximidoyl chloride, and N ‐phenylbenzenecarboximidoyl chloride were prepared according to previously reported procedures . The imine‐N‐heterocyclic carbene ligands L1–L4 , L5 ,– L6–L9 , and L10 – were prepared according to slightly modified procedures reported previously. For the biological experiments, Dulbecco′s Modified Eagle′s Medium (DMEM), fetal bovine serum, penicillin/streptomycin mixture, trypsin/EDTA, phosphate‐buffered saline (PBS), MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide), PI (propidium iodide), JC‐1 (5,5′,6,6′‐tetrachloro‐1,1′,3,3′‐tetraethylbenzimidazolyl carbocyanine iodide), and H 2 DCFDA (2′,7′‐dichlorodihydrofluorescein diacetate) were purchased from Sangon Biotech.…”